Braeburn Pharmaceuticals | search
Click here to view Braeburn Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Homepage | BraeburnStart. Stop. Learn More. explore our thought leadership. At Braeburn, there are opportunities to contribute to our purpose every day. We value authenticity and strive to amplify all voices. Our culture empowers everyone to be successful and unleashes our full potential.
- R&D - BraeburnBraeburn’s commitment to transforming the management of opioid use disorder is reflected in our research and development priorities. We are dedicated to working with the healthcare community in order to advance research, education, and support to help end the opioid epidemic.
- FDA clears Braeburn's Brixadi to treat opioid use disorder - Fierce PharmaRight after approving a new overdose reversal therapy, the FDA gave Braeburn's long-acting Brixadi an endorsement to treat opioid use disorder.
- Media - BraeburnOur blog, titled Recovery Connections, features posts about Braeburn's community engagement, advocacy and insights on substance use disorder policies.
- Braeburn Pharmaceuticals Announces FDA Approves Probuphine ...Braeburn's investigational product pipeline consists of long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including opioid addiction, pain,...
More
